IDH1 and central nervous system cancer: We assessed the performance of our method for grading glioma, glioma isocitrate dehydrogenase1 (IDH1) mutation status classification and pituitary tumor texture classification on two datasets, glioma or pituitary tumors collected in a local affiliated hospital and glioma imaging data from TCIA.